Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 04-2019 | 01-2019 | 10-2018 | 07-2018 | 04-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14 | 23 | 70 | 38 | 101 |
| Receivables | 77 | 109 | 116 | 81 | 98 |
| Inventories | 47 | 62 | 31 | 59 | 21 |
| TOTAL | $138 | $194 | $231 | $178 | $220 |
| Non-Current Assets | |||||
| PPE Net | 0 | 0 | 0 | 0 | 86 |
| TOTAL | $0 | $0 | $0 | $0 | $86 |
| Total Assets | $138 | $194 | $232 | $178 | $306 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 166 | 91 | 82 | 30 | 64 |
| Accrued Expenses | 24 | 18 | 23 | 33 | 206 |
| TOTAL | $193 | $109 | $109 | $66 | $276 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $193 | $109 | $109 | $66 | $276 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 4,192 | 0 | 0 |
| Retained earnings | -4,302 | -4,163 | -4,125 | -4,135 | -4,340 |
| Other shareholders' equity | 56 | 56 | 56 | 56 | 178 |
| TOTAL | $-54 | $85 | $123 | $113 | $30 |
| Total Liabilities And Equity | $138 | $194 | $232 | $178 | $306 |